| Literature DB >> 35819797 |
Shanshan Chen1, Ming Hu1, Anqun Hu1, Yang Xue1, Si Wang1, Fan Liu1, Chuhao Li1, Xiaofan Zhou1, Jianuan Zhou1.
Abstract
Dickeya zeae is an aggressive bacterial phytopathogen that infects a wide range of host plants. It has been reported that integration host factor (IHF), a nucleoid-associated protein consisting of IHFα and IHFβ subunits, regulates gene expression by influencing nucleoid structure and DNA bending. To define the role of IHF in the pathogenesis of D. zeae MS2, we deleted either and both of the IHF subunit encoding genes ihfA and ihfB, which significantly reduced the production of cell wall-degrading enzymes (CWDEs), an unknown novel phytotoxin and the virulence factor-modulating (VFM) quorum-sensing (QS) signal, cell motility, biofilm formation, and thereafter the infection ability towards both potato slices and banana seedlings. To characterize the regulatory pathways of IHF protein associated with virulence, IHF binding sites (consensus sequence 5'-WATCAANNNNTTR-3') were predicted and 272 binding sites were found throughout the genome. The expression of 110 tested genes was affected by IHF. Electrophoretic mobility shift assay (EMSA) showed direct interaction of IhfA protein with the promoters of vfmE, speA, pipR, fis, slyA, prtD, hrpL, hecB, hcp, indA, hdaA, flhD, pilT, gcpJ, arcA, arcB, and lysR. This study clarified the contribution of IHF in the pathogenic process of D. zeae by controlling the production of VFM and putrescine QS signals, phytotoxin, and indigoidine, the luxR-solo system, Fis, SlyA, and FlhD transcriptional regulators, and secretion systems from type I to type VI. Characterization of the regulatory networks of IHF in D. zeae provides a target for prevention and control of plant soft rot disease.Entities:
Keywords: zzm321990Dickeya zeaezzm321990; DNA binding; cell motility; cell wall-degrading enzymes; integration host factor; transcriptional regulator; virulence
Mesh:
Substances:
Year: 2022 PMID: 35819797 PMCID: PMC9452768 DOI: 10.1111/mpp.13244
Source DB: PubMed Journal: Mol Plant Pathol ISSN: 1364-3703 Impact factor: 5.520
Gene candidates harbouring the IHF binding motif predicted in Dickeya zeae MS2 genome and their expression in ihfA and ihfB mutants in comparison to the wild type
| Function category | Gene | Locus (C1O30_) | Product | Binding site (5′‐WATCAANNNNTTR‐3′) | Position from start codon | Log2 fold change of gene expression | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Δ | Δ | Δ | |||||||||
| Signal transduction |
| RS00505 | AraC family transcriptional regulator | AATCAACCACT | −99 to −73 | −3.01 ± 0.16 | ↓ | −5.01 ± 0.09 | ↓ | −2.61 ± 0.13 | ↓ |
|
| RS00610 | LuxR family transcriptional regulator | AAT | −234 to −208 | 0.01 ± 0.05 | – | −0.10 ± 0.09 | – | −0.18 ± 0.07 | – | |
|
| RS00615 | Acyl‐homoserine‐lactone synthase | AATCAAGCAAT | −100 to −74 | 0.08 ± 0.14 | – | −0.29 ± 0.27 | – | −0.56 ± 0.14 | – | |
| / | RS05855 | TonB‐dependent siderophore receptor | TATCAACAATTT | −69 to −43 | −4.32 ± 0.23 | ↓ | −4.01 ± 0.06 | ↓ | −4.22 ± 0.41 | ↓ | |
|
| RS09785 | Sensor histidine kinase regulating citrate/malate metabolism | AATCAAATGATTG | −309 to −283 | 0.05 ± 0.08 | – | −3.11 ± 0.13 | ↓ | −1.49 ± 0.16 | ↓ | |
|
| RS11960 | Nitrate/nitrite two‐component system sensor histidine kinase NarX |
| −377 to −351 | −1.64 ± 0.14 | ↓ | −0.74 ± 0.30 | – | −0.91 ± 0.10 | – | |
|
| RS11965 | Two‐component system response regulator NarL | AATCAACGGCT | −390 to −364 | −3.15 ± 0.14 | ↓ | −0.66 ± 0.12 | – | −1.73 ± 0.19 | ↓ | |
|
| RS14530 | LuxR‐solo transcriptional regulator | TATCAACGCG | 547 to −521 | −4.13 ± 0.62 | ↓ | −4.99 ± 0.53 | ↓ | −3.42 ± 0.44 | ↓ | |
|
| RS14535 | Proline iminopeptidase‐family hydrolase | No box | – | −4.94 ± 0.28 | ↓ | −5.42 ± 0.50 | ↓ | −3.23 ± 0.12 | ↓ | |
|
| RS18265 | Arginine decarboxylase | AATCAATAATT | −766 to −739 | −3.17 ± 0.36 | ↓ | −2.47 ± 0.12 | ↓ | −3.81 ± 0.32 | ↓ | |
|
| RS04655 | Ornithine decarboxylase | No box | – | −0.70 ± 0.12 | ↓ | −1.61 ± 0.59 | ↓ | −2.25 ± 0.34 | ↓ | |
|
| RS18960 | Acid pH activated two‐component system sensor histidine kinase PmrB | AATCAACAGGTTA | −268 to −242 | −1.94 ± 0.33 | ↓ | −3.78 ± 0.14 | ↓ | −2.90 ± 0.08 | ↓ | |
| Cell wall‐degrading enzymes |
| RS10815 | AprI/Inh family metalloprotease inhibitor Inh | TATCAATGTCTT | −84 to −58 | −1.78 ± 1.31 | ↓ | −2.27 ± 1.29 | ↓ | −1.54 ± 0.54 | ↓ |
|
| RS15350 | Polysaccharide lyase PelE | AATCAACTCATTG | −269 to −243 | −0.04 ± 0.13 | – | −0.22 ± 0.22 | – | −0.46 ± 0.32 | – | |
| Type I secretion system |
| RS10810 | Type I secretion system permease/ATPase Prentry | TATCAATGTCTT | −463 to −437 | −2.47 ± 0.20 | ↓ | −3.27 ± 0.16 | ↓ | −2.34 ± 0.54 | ↓ |
| Type II secretion system |
| RS14420 | Type II secretion system protein GspC |
| −723 to −697 | −2.63 ± 0.08 | ↓ | −3.52 ± 0.54 | ↓ | −2.53 ± 0.08 | ↓ |
| Type III secretion system |
| RS11655 | RNA polymerase σ factor HrpL | TA | −234 to −208 | −2.26 ± 0.04 | ↓ | −4.34 ± 0.27 | ↓ | −2.68 ± 0.03 | ↓ |
| Type IV secretion system |
| RS03620 | Type IV secretion protein Rhs |
| +455 to +482 | −2.98 ± 0.22 | ↓ | −4.85 ± 0.06 | ↓ | −2.65 ± 0.11 | ↓ |
|
| RS06845 | Type IV secretion protein Rhs |
| −865 to −839 | −3.45 ± 0.30 | ↓ | −4.01 ± 0.10 | ↓ | −5.28 ± 0.15 | ↓ | |
| Type V secretion system |
| RS11555 | HecB hemolysin secretion protein HecB | AATCAATGGGTTG | −150 to −124 | −3.22 ± 0.07 | ↓ | −4.37 ± 0.30 | ↓ | −1.84 ± 0.36 | ↓ |
| Type VI secretion syste |
| RS03605 | Hcp family type VI secretion protein | AATCAAGAATTT | −883 to −857 | −5.05 ± 0.11 | ↓ | −7.02 ± 0.23 | ↓ | −5.01 ± 0.08 | ↓ |
| Secondary metabolite synthesis |
| RS00465 | Indigoidine synthase IndA | TAT | −268 to −241 | −1.71 ± 0.13 | ↓ | −4.62 ± 0.13 | ↓ | −3.96 ± 0.55 | ↓ |
|
| RS05020 | Hypothetical protein | AA | −224 to −197 | −3.22 ± 0.14 | ↓ | −3.11 ± 0.16 | ↓ | −4.25 ± 0.14 | ↓ | |
|
| RS05075 | Nonribosomal peptide synthetase | No box | – | −4.29 ± 0.44 | ↓ | −5.37 ± 0.22 | ↓ | −5.97 ± 0.24 | ↓ | |
|
| RS06215 | Flavodoxin FldA | AATCAACTAATTG | −35 to −9 | 0.56 ± 0.08 | – | 0.10 ± 0.09 | – | 0.20 ± 0.20 | – | |
| Motility and chemotaxis |
| RS02500 | Methyl‐accepting chemotaxis protein | AATCAATTAATTG | −180 to −154 | −2.27 ± 0.06 | ↓ | −3.62 ± 0.18 | ↓ | −2.38 ± 0.24 | ↓ |
|
| RS02880 | Methyl‐accepting chemotaxis protein | TATCAATAAGTTA | −262 to −236 | −3.45 ± 0.01 | ↓ | −4.84 ± 0.39 | ↓ | −3.21 ± 0.62 | ↓ | |
|
| RS08665 | Shufflon system plasmid conjugative transfer pilus tip adhesin PilV | TATCAATGTGTT | −131 to −105 | −3.40 ± 0.13 | ↓ | −5.03 ± 0.16 | ↓ | −3.18 ± 0.22 | ↓ | |
|
| RS09065 | Outer membrane protein OmpX | AATCAAAAAATTA | −243 to −217 | −1.51 ± 0.07 | ↓ | −0.87 ± 0.06 | – | −0.85 ± 0.04 | – | |
|
| RS09390 | Methyl‐accepting chemotaxis protein | TATCA | −626 to −599 | 1.30 ± 0.34 | ↑ | 1.08 ± 1.22 | ↑ | 1.53 ± 1.06 | ↑ | |
|
| RS12040 | HAMP domain‐containing protein |
| −494 to −468 | 1.28 ± 0.21 | ↑ | 0.09 ± 0.06 | – | 0.96 ± 0.05 | – | |
|
| RS13530 | Chemotaxis protein CheA | TATCAAACATTT | +5 to +31 | 1.49 ± 0.10 | ↑ | 1.36 ± 0.21 | ↑ | 0.01 ± 0.02 | – | |
|
| RS13550 | Flagellar transcriptional regulator FlhD | TATCAATTGCTTA | −485 to −459 | −1.28 ± 0.14 | ↓ | −2.51 ± 0.62 | ↓ | −1.24 ± 0.08 | ↓ | |
|
| RS14140 | HAMP domain‐containing protein | TATCAATCATTT | −445 to −419 | −0.77 ± 0.08 | – | −0.97 ± 0.04 | – | −0.94 ± 0.05 | – | |
|
| RS17065 | Type IV pilus twitching motility protein PilT | TATC | −252 to −226 | −4.17 ± 0.43 | ↓ | −5.42 ± 0.32 | ↓ | −3.31 ± 0.12 | ↓ | |
|
| RS20725 | Methyl‐accepting chemotaxis protein | AATCAAGCGC | −580 to −554 | −1.27 ± 0.18 | ↓ | −2.44 ± 0.18 | ↓ | −1.77 ± 0.16 | ↓ | |
| c‐di‐GMP |
| RS06990 | Sensor domain‐containing diguanylate cyclase DGC | TATCAAGCAGTT | −761 to −735 | −1.49 ± 0.10 | ↓ | −3.30 ± 0.18 | ↓ | −1.72 ± 0.22 | ↓ |
|
| RS14540 | Diguanylate cyclase DGC | TATCA | −479 to −453 | −3.46 ± 0.34 | ↓ | −5.82 ± 0.26 | ↓ | −4.34 ± 0.43 | ↓ | |
|
| RS15425 | Sensor domain‐containing diguanylate cyclase DGC | TATCAAAATATTA | −315 to −289 | 1.77 ± 0.06 | ↑ | 1.43 ± 0.18 | ↑ | 0.25 ± 0.46 | – | |
| Capsular polysaccharide synthesis |
| RS02585 | Undecaprenyl‐phosphate glucose phosphotransferase WcaJ | TATCAATCAATT | +54 to +80 | −3.34 ± 0.07 | ↓ | −5.28 ± 0.10 | ↓ | −4.45 ± 0.11 | ↓ |
|
| RS02600 | Polysaccharide biosynthesis tyrosine autokinase CpsD |
| −97 to −71 | −4.02 ± 0.58 | ↓ | −6.00 ± 0.59 | ↓ | −5.61 ± 0.08 | ↓ | |
| / | RS02605 | Capsular biosynthesis protein | TATCAACGGATTG | −300 to −274 | −3.10 ± 0.14 | ↓ | −4.81 ± 0.12 | ↓ | −3.87 ± 0.37 | ↓ | |
| / | RS02615 | Glycosyltransferase |
| −8 to +16 | −4.07 ± 0.25 | ↓ | −5.79 ± 0.09 | ↓ | −4.84 ± 0.26 | ↓ | |
|
| RS06590 | Polysaccharide export protein Wza |
| −131 to −105 | −2.14 ± 0.36 | ↓ | −5.02 ± 0.60 | ↓ | −3.39 ± 0.17 | ↓ | |
|
| RS06605 | Glycosyltransferase family 4 protein WcaA | TATCAATACCTTA | +1 to +27 | −2.81 ± 0.31 | ↓ | −2.02 ± 0.21 | ↓ | −2.53 ± 0.33 | ↓ | |
| / | RS06620 | Glycosyltransferase family 2 protein | AATCAAGGCGTT | −561 to −535 | −3.30 ± 0.03 | ↓ | −3.97 ± 0.14 | ↓ | −2.97 ± 0.19 | ↓ | |
| / | RS06690 | Glycosyltransferase | AATCAAGGCGTTG | −222 to −196 | −3.84 ± 0.32 | ↓ | −2.54 ± 0.04 | ↓ | −2.07 ± 0.06 | ↓ | |
| Stress resistance |
| RS01695 | Aerobic respiration two‐component sensor histidine kinase ArcB | AATCA | −6 to +20 | −1.30 ± 0.32 | ↓ | −1.28 ± 0.47 | ↓ | −1.31 ± 0.34 | ↓ |
| / | RS08685 | DHA2 family efflux MFS transporter permease subunit | TATCAATAGATT | −161 to −135 | −3.64 ± 0.31 | ↓ | −4.13 ± 0.11 | ↓ | −2.70 ± 0.07 | ↓ | |
| / | RS09235 | Bcr/CflA family multidrug efflux MFS transporter | AA | −133 to −107 | −3.36 ± 0.09 | ↓ | −3.89 ± 0.36 | ↓ | −3.72 ± 0.16 | ↓ | |
|
| RS09440 | Biosurfactant synthesis, colonization of plant surface, alpha/beta hydrolase | TATCAAACAGTT | −502 to −476 | −3.92 ± 0.30 | ↓ | −4.06 ± 0.14 | ↓ | −3.64 ± 0.24 | ↓ | |
|
| RS11525 | Type I toxin‐antitoxin system SymE family toxin |
| −565 to −539 | −1.94 ± 0.29 | ↓ | −4.48 ± 0.36 | ↓ | −2.69 ± 0.14 | ↓ | |
|
| RS16150 | Type I toxin‐antitoxin system antitoxin YafN | AATCAATTTTTTG | −107 to −81 | −1.97 ± 0.10 | ↓ | −2.54 ± 0.03 | ↓ | −1.40 ± 0.20 | ↓ | |
|
| RS16475 | Glycine betaine/L‐proline ABC transporter ATP‐binding protein ProV | AATCAACACGTTG | −253 to −227 | −1.04 ± 0.04 | ↓ | −2.17 ± 0.04 | ↓ | −1.61 ± 0.22 | ↓ | |
|
| RS17225 | Envelope stress response protein PspG | AATCAATGCGTTA | −138 to −112 | −2.25 ± 0.37 | ↓ | −4.69 ± 0.30 | ↓ | −3.14 ± 0.21 | ↓ | |
|
| RS18160 | MDR efflux pump AcrAB transcriptional activator RobA | AATCAAATTCTT | −129 to −103 | −1.51 ± 0.11 | ↓ | −1.24 ± 0.03 | ↓ | −1.84 ± 0.36 | ↓ | |
| Metabolic process |
| RS00425 | Sugar ABC transporter permease XylH |
| −193 to −167 | −2.74 ± 0.03 | ↓ | −4.16 ± 0.04 | ↓ | −2.72 ± 0.17 | ↓ |
|
| RS01700 | Isoprenoid biosynthesis glyoxalase ElbB | AATCAATTAGTTG | −52 to −26 | 0.11 ± 0.02 | – | −0.40 ± 0.10 | – | −1.35 ± 0.05 | ↓ | |
| / | RS02510 | GNAT family N‐acetyltransferase | TATCAACAGCTT | −82 to −56 | −3.15 ± 0.16 | ↓ | −4.30 ± 0.08 | ↓ | −4.72 ± 0.22 | ↓ | |
|
| RS03185 | Lactaldehyde reductase FucO | AATCAATACATTA | −41to −15 | −0.38 ± 0.24 | – | −0.77 ± 0.15 | – | −1.44 ± 0.17 | ↓ | |
|
| RS03385 | Cation/acetate symporter ActP | TATCAACGGATTG | −307 to −281 | −1.19 ± 0.06 | ↓ | −1.68 ± 0.05 | ↓ | −2.85 ± 0.14 | ↓ | |
|
| RS05305 | Phosphate response regulator transcription factor PhoB | TATCA | +65 to +91 | −3.26 ± 0.37 | ↓ | −3.68 ± 0.23 | ↓ | −2.37 ± 0.05 | ↓ | |
|
| RS06280 | K+‐transporting ATPase subunit F |
| −336 to −310 | −2.97 ± 0.15 | ↓ | −3.64 ± 0.21 | ↓ | −1.90 ± 0.30 | ↓ | |
| / | RS07470 | SDR family oxidoreductase | AATCAAAATATTG | −165 to −139 | −2.29 ± 0.37 | ↓ | −4.48 ± 0.04 | ↓ | −3.31 ± 0.11 | ↓ | |
|
| RS08935 | Secretion protein HlyD | TATCAATTAGTTA | −258 to −232 | 0.17 ± 0.09 | – | 0.02 ± 0.20 | – | 0.35 ± 0.09 | – | |
|
| RS08995 | DeoR/GlpR transcriptional regulator | TATCAACTTGTT | −182 to −156 | −1.50 ± 0.03 | ↓ | −1.58 ± 0.32 | ↓ | −2.18 ± 0.20 | ↓ | |
|
| RS11160 | Disulphide bond formation protein DsbB | TATCAAATAGTTA | −770 to −744 | −6.45 ± 0.24 | ↓ | −1.95 ± 0.18 | ↓ | −1.51 ± 0.10 | ↓ | |
|
| RS12295 | L‐lactate permease LctP | TATCAATAAGTTA | −50 to −24 | 1.97 ± 0.09 | ↑ | 0.31 ± 0.13 | – | 0.80 ± 0.09 | – | |
|
| RS13040 | PTS sugar transporter subunit IIC PtsG | TATCAAACATTTG | −173 to −147 | −1.43 ± 0.07 | ↓ | −3.20 ± 0.12 | ↓ | −1.80 ± 0.16 | ↓ | |
|
| RS13300 | SDR family oxidoreductase FabG | AATCAAATTTTTG | −238 to −212 | −1.10 ± 0.16 | ↓ | 1.62 ± 0.07 | ↑ | 0.31 ± 0.25 | – | |
| / | RS13660 | Glycosyltransferase family 1 protein | TATCA | −199 to −173 | −3.62 ± 0.18 | ↓ | −4.26 ± 0.36 | ↓ | −3.55 ± 0.03 | ↓ | |
|
| RS16340 | D‐sedoheptulose 7‐phosphate isomerase GmhA | TATCAATTCATT | −285 to −259 | 0.02 ± 0.14 | – | −0.85 ± 0.21 | – | −0.28 ± 0.26 | – | |
| / | RS16795 | D‐galactonate transporter MFS | TATCAACTGGTTA | −697 to −671 | −1.81 ± 0.15 | ↓ | −1.32 ± 0.06 | ↓ | −1.59 ± 0.35 | ↓ | |
| / | RS17250 | Transporter substrate‐binding domain‐containing protein | AATCAACGAGTTA | −125 to −99 | −4.17 ± 0.37 | ↓ | −2.13 ± 0.31 | ↓ | −2.52 ± 0.22 | ↓ | |
|
| RS18640 | Malate synthase A AceE | AATCAAATAGTTG | −177 to −151 | −0.93 ± 0.11 | – | −1.62 ± 0.03 | ↓ | −1.21 ± 0.21 | ↓ | |
| / | RS20745 | NAD(P)/FAD‐dependent oxidoreductase | AATCAATGCATTA | −180 to −154 | −1.85 ± 0.03 | ↓ | −3.89 ± 0.10 | ↓ | −3.01 ± 0.13 | ↓ | |
| Amino acid transport | / | RS08960 | ABC transporter substrate‐binding protein | AATCAAAGGCTT | −75 to −49 | −2.07 ± 0.13 | ↓ | −2.67 ± 0.12 | ↓ | −1.85 ± 0.29 | ↓ |
| / | RS09455 | Aspartate:alanine antiporter | TATCAATAATTTA | −52 to −26 | −1.97 ± 0.23 | ↓ | −2.42 ± 0.35 | ↓ | −1.92 ± 0.16 | ↓ | |
| / | RS13315 | DegT/DnrJ/EryC1/StrS family aminotransferase | AATCAATATATTA | +68 to +94 | 1.09 ± 0.24 | ↑ | 1.41 ± 0.06 | ↑ | 1.07 ± 0.54 | ↑ | |
| Replication, recombination, and repair |
| RS01885 | CRISPR‐associated helicase/endonuclease Cas3 | AATCAACATGTTG | −366 to −340 | 0.56 ± 0.17 | – | 0.37 ± 0.18 | – | −0.80 ± 0.07 | – |
|
| RS02700 | Bacteriophage exclusion‐mediated protein FxsA | TATCAATGAGTTA | −51 to −25 | −1.02 ± 0.14 | ↓ | −1.96 ± 0.16 | ↓ | −2.33 ± 0.12 | ↓ | |
|
| RS03105 | Deoxyribose‐phosphate aldolase DeoC | TATCAATAAGTTA | −940 to −914 | −1.01 ± 0.08 | ↓ | −1.84 ± 0.21 | ↓ | −1.61 ± 0.08 | ↓ | |
|
| RS04625 | DNA cytosine methyltransferase Dcm | AATCAACTTATTA | −360 to −334 | −1.10 ± 0.08 | ↓ | −1.40 ± 0.06 | ↓ | −3.63 ± 0.02 | ↓ | |
|
| RS04995 | Rho‐binding antiterminator | TATCAACCCATTA | +5 to +31 | −2.38 ± 0.15 | ↓ | −2.18 ± 0.28 | ↓ | −3.22 ± 0.42 | ↓ | |
| – | RS08595 | DNA‐directed RNA polymerase subunit β | TATCAATTGGTTA | −137 to −111 | −2.07 ± 0.09 | ↓ | 0.53 ± 0.03 | – | −2.32 ± 0.21 | ↓ | |
| / | RS08690 | Integrase arm‐type DNA‐binding domain‐containing protein | TATCAATCAGTTA | −148 to −122 | −2.83 ± 0.23 | ↓ | −3.72 ± 0.13 | ↓ | −3.41 ± 0.04 | ↓ | |
|
| RS11295 | Transcription antiterminator/RNA stability regulator CspE | AATCAAATGGTTG | −361 to −335 | 1.60 ± 0.19 | ↑ | 1.49 ± 0.18 | ↑ | 2.16 ± 0.21 | ↑ | |
|
| RS12370 | tRNA 2‐thiocytidine(32) synthetase TtcA | AATCAATCCGTTA | −5to +21 | −3.07 ± 0.29 | ↓ | −1.75 ± 0.13 | ↓ | −2.47 ± 0.32 | ↓ | |
| / | RS16155 | Site‐specific integrase | AATCAAATGATTA | −118 to −82 | −0.26 ± 0.09 | – | −1.45 ± 0.13 | ↓ | −1.26 ± 0.05 | ↓ | |
|
| RS16230 | BREX phage resistance system P‐loop protein BrxC | AATCAAGAGTTTG | −262 to −236 | −5.06 ± 0.47 | ↓ | −3.29 ± 0.40 | ↓ | −3.24 ± 0.47 | ↓ | |
| Transcriptional regulators |
| RS00380 | MltR family transcriptional regulator |
| −404 to −378 | −3.56 ± 0.14 | ↓ | −4.95 ± 0.17 | ↓ | −4.80 ± 0.06 | ↓ |
|
| RS01395 | DNA‐binding transcriptional regulator Fis | A | −108 to −81 | −4.03 ± 0.22 | ↓ | −4.90 ± 0.08 | ↓ | −4.31 ± 0.25 | ↓ | |
|
| RS03435 | MarR family transcriptional regulator | TATCAATCAA | −124 to −98 | −2.70 ± 0.06 | ↓ | −4.17 ± 0.39 | ↓ | −2.15 ± 0.11 | ↓ | |
| / | RS04230 | LuxR C‐terminal‐related transcriptional regulator | AATCAAAGAATTA | −95 to −68 | −3.06 ± 0.11 | ↓ | −5.01 ± 0.47 | ↓ | −3.48 ± 0.20 | ↓ | |
| / | RS04275 | HxlR family transcriptional regulator | AATCAAGTTTTT | −483 to −457 | −2.60 ± 0.37 | ↓ | −4.48 ± 0.36 | ↓ | −4.01 ± 0.10 | ↓ | |
| / | RS04455 | LysR family transcriptional regulator | AATCAAACCATT | −269 to −243 | −1.19 ± 0.06 | ↓ | −1.68 ± 0.05 | ↓ | −2.85 ± 0.14 | ↓ | |
|
| RS07705 | Formate hydrogenlyase transcriptional activator FlhA |
| −107 to −81 | −0.61 ± 0.05 | – | −0.86 ± 0.04 | – | −0.61 ± 0.16 | – | |
|
| RS08480 | H‐NS histone family protein | AAT | −328 to −302 | −2.45 ± 0.09 | ↓ | −3.58 ± 0.27 | ↓ | −2.00 ± 0.26 | ↓ | |
|
| RS08660 | H‐NS histone family protein | AAT | −154 to −128 | −2.02 ± 0.09 | ↓ | −2.83 ± 0.08 | ↓ | −2.78 ± 0.22 | ↓ | |
|
| RS09135 | Metalloregulator ArsR/SmtB family transcription factor | TATC | −181 to −155 | −3.83 ± 0.08 | ↓ | −3.88 ± 0.38 | ↓ | −4.48 ± 0.14 | ↓ | |
|
| RS09615 | Leucine‐responsive transcriptional regulator Lrp | AATCAATAGTTTA | −549 to −523 | −2.84 ± 0.08 | ↓ | −0.16 ± 0.11 | – | −1.41 ± 0.35 | ↓ | |
| / | RS10685 | ROK family transcriptional regulator | AATCAAATATTTG | −121 to −95 | 0.36 ± 0.24 | – | −1.25 ± 0.01 | ↓ | 0.05 ± 0.31 | – | |
|
| RS13650 | LysR family transcriptional regulator | AATCAAATTATTG | −312 to −286 | −3.31 ± 0.15 | ↓ | −4.74 ± 0.29 | ↓ | −3.55 ± 0.15 | ↓ | |
|
| RS15045 | LysR family transcriptional regulator | AATC | −62 to −36 | −2.60 ± 0.19 | ↓ | −3.85 ± 0.21 | ↓ | −1.99 ± 0.35 | ↓ | |
|
| RS17210 | GntR family transcriptional regulator MngR | TATCAAGGCTTT | −32 to −6 | −5.04 ± 0.13 | ↓ | −4.65 ± 0.28 | ↓ | −3.48 ± 0.39 | ↓ | |
| – | RS18450 | MarR family transcriptional regulator | TATCAAAAGGTTA | −106 to −80 | −1.35 ± 0.26 | ↓ | −1.26 ± 0.20 | ↓ | −1.92 ± 0.06 | ↓ | |
| Hypothetical proteins | / | RS00200 | DUF3861 domain‐containing protein | TATCAACTATTTG | −108 to −82 | −2.88 ± 0.10 | ↓ | −4.46 ± 0.03 | ↓ | −3.47 ± 0.13 | ↓ |
| / | RS01690 | TIGR01212 family radical SAM protein | AATCAATATGTT | +4 to +30 | −2.86 ± 0.13 | ↓ | −2.87 ± 0.16 | ↓ | −3.00 ± 0.23 | ↓ | |
| / | RS02900 | Hypothetical protein | AATCAAAATATTA | −341 to −315 | −3.61 ± 0.24 | ↓ | −4.14 ± 0.24 | ↓ | −2.99 ± 0.01 | ↓ | |
| / | RS03390 | DUF485 domain‐containing protein | TATCAACGGATTG | +2 to +28 | −1.10 ± 0.08 | ↓ | −1.40 ± 0.06 | ↓ | −3.63 ± 0.02 | ↓ | |
| / | RS03400 | Hypothetical protein | TATCAACGGTTTG | −151 to −125 | −2.00 ± 0.08 | ↓ | −2.58 ± 0.54 | ↓ | −2.82 ± 0.28 | ↓ | |
| / | RS03585 | Hypothetical protein | AATCAACGGGTT | −378 to −352 | −1.57 ± 0.46 | ↓ | −2.51 ± 0.05 | ↓ | −1.93 ± 0.25 | ↓ | |
| / | RS03590 | Hypothetical protein | AATCAACGGGTT | +30 to +56 | −2.38 ± 0.15 | ↓ | −2.18 ± 0.28 | ↓ | −3.22 ± 0.42 | ↓ | |
| / | RS04495 | IGR00645 family protein | AATCAATGTGTTA | −109 to −83 | −1.62 ± 0.64 | ↓ | −2.82 ± 0.17 | ↓ | −2.67 ± 0.29 | ↓ | |
| / | RS05170 | Hypothetical protein | TATCAATATCTTG | +32 to +58 | −2.60 ± 0.37 | ↓ | −4.48 ± 0.36 | ↓ | −4.01 ± 0.10 | ↓ | |
| / | RS06855 | Hypothetical protein | AATCAAATGATTG | −20 to +6 | −1.70 ± 0.16 | ↓ | −3.10 ± 0.14 | ↓ | −1.36 ± 0.09 | ↓ | |
| / | RS06880 | Hypothetical protein |
| −12 to +14 | −6.34 ± 0.62 | ↓ | −4.26 ± 0.95 | ↓ | −4.49 ± 0.17 | ↓ | |
| / | RS07745 | DUF4160 domain‐containing protein | AATCAAATCATTG | −477 to −451 | −2.54 ± 0.25 | ↓ | −3.23 ± 0.34 | ↓ | −3.46 ± 0.20 | ↓ | |
| / | RS08605 | Hypothetical protein | AATCAACTCGTT | −587 to −561 | −0.83 ± 0.21 | – | −1.52 ± 0.08 | ↓ | −1.91 ± 0.15 | ↓ | |
| / | RS09035 | DUF1349 domain‐containing protein | AATCAATACGTTA | −50 to −24 | −2.38 ± 0.31 | ↓ | −3.82 ± 0.13 | ↓ | −4.29 ± 0.23 | ↓ | |
| – | RS10060 | Hypothetical protein | AATCAATGAATTG | −250 to −224 | −2.71 ± 0.26 | ↓ | −6.51 ± 1.14 | ↓ | −3.41 ± 0.10 | ↓ | |
| / | RS10540 | YolA family protein | TATCAACTTATTG | −427 to −401 | −3.00 ± 0.21 | ↓ | −0.63 ± 0.08 | – | −1.66 ± 0.12 | ↓ | |
| / | RS10730 | Hypothetical protein | AATCAACATGTTA | −58 to −32 | −1.33 ± 0.26 | ↓ | −1.54 ± 0.13 | ↓ | −1.76 ± 0.17 | ↓ | |
| / | RS10850 | Hypothetical protein | AATCAAATAATTA | −523 to −497 | −0.95 ± 0.18 | – | −1.47 ± 0.12 | ↓ | −3.15 ± 0.12 | ↓ | |
| / | RS11855 | DUF1852 domain‐containing protein | TATCAATGCATTA | −67 to −41 | −1.43 ± 0.25 | ↓ | −0.16 ± 0.02 | – | −2.61 ± 0.22 | ↓ | |
| / | RS12735 | Hypothetical protein | TATCAATAGGTTG | −316 to −290 | −2.58 ± 1.00 | ↓ | −3.95 ± 1.23 | ↓ | −2.14 ± 0.51 | ↓ | |
| / | RS13635 | Hypothetical protein | AATCAAGAGATTA | −398 to −372 | 1.45 ± 0.13 | ↑ | 0.44 ± 0.20 | – | 0.28 ± 0.09 | – | |
| – | RS14145 | Hypothetical protein | TATCAACGTTTTG | −291 to −265 | −4.10 ± 0.06 | ↓ | −3.38 ± 0.18 | ↓ | −3.32 ± 0.21 | ↓ | |
Notes: Genes with statistically significant changes in expression (|log2 fold change of expression| ≥ 1 and p ≤ 0.05) were selected.
Italics represent the mismatch of binding sites.
↓ represents down‐regulation of gene expression, ↑ represents up‐regulation of gene expression, – represents no significant change in gene expression. Data are the results of at least three independent biological replicates and are means ± SD.
FIGURE 1Electrophoretic mobility shift assay of IhfA protein with predicted gene promoters. 1 nM of labelled probe of C1O30_RS12170, vfmE, speA, speC, pipR, fis, slyA, prtD, gspC, hrpL, hecB, hcp, indA, hdaA, flhD, pilT, gcpJ, arcA, arcB, and lysR genes was incubated with 0–5 μM IhfA. 100 nM unlabelled corresponding probes were used as the specific competitors before adding 1 nM of the labelled probes in different reactions. The positions of free DNA and of IhfA–DNA complexes are shown
FIGURE 2IHF regulates the production of VFM rather than the AHL quorum‐sensing (QS) signal. (a) AHL signal diffusion assay of Dickeya zeae MS2, ∆ihfA, and ∆ihfB. Strains were spotted on the top of the agar strips and Agrobacterium tumefaciens CF11 (tra‐lacZ) was used as a biosensor for the AHL QS signal (Hussain et al., 2008). (b) VFM QS signal detection of D. zeae MS2, ∆ihfA, ∆ihfB, ∆ihfAB, and complemented strains ∆ihfA::ihfA and ∆ihfB::ihfB. Different concentrations of bacterial supernatants were co‐cultured with the reporter strain in medium supplemented with X‐Gal at 30°C with 200 rpm for 12 h (Lv et al., 2019). CK, negative control. Experiments were repeated three times in triplicate
FIGURE 3IHF regulates the production of cell wall‐degrading enzymes and phytotoxin. (a) IHF contributes to cell wall degrading enzymatic activities. (b) IHF significantly modulates phytotoxin production of Dickeya zeae MS2. The results were averaged over the three replicates and the error bars represent standard deviations. *p < 0.05, ***p < 0.0001; ns, not significant (Student's t test) (n = 3 independent experiments)
FIGURE 4IHF regulates cell motility and biofilm formation of Dickeya zeae MS2. (a) Swarming, swimming, and twitching motilities of MS2 and its derivatives. (b) Nonadherent biofilms of MS2 and its derivatives formed at the air/liquid interface. (c) Attached biofilms of MS2 and its derivatives measured by crystal violet staining. The experimental results were averaged over the three replicates and the error bars represent standard deviations (SD). *p < 0.05, **p < 0.001, ***p < 0.0001; ns, not significant (Student's t test) (n = 3 independent experiments)
FIGURE 5Deletion of ihf genes and gcpJ decreases c‐di‐GMP concentration in Dickeya zeae MS2. c‐di‐GMP concentrations of mutants and complemented stains were normalized to that of the wild‐type MS2, which was set to 100%. The experimental results were averaged over the three replicates and the error bars represent standard deviations (SD). **p < 0.001, ***p < 0.0001, ns, not significant (Student's t test) (n = 3 independent experiments)
FIGURE 6Deletion of ihf genes reduces the virulence of Dickeya zeae MS2. (a) Virulence of MS2 and ihf mutants on banana seedlings. Each banana seedling was inoculated with 200 μl of fresh bacterial culture (OD600 1.0) and kept in an incubator at 28°C with 12‐h alternating light–dark cycles for 14 days. Three biological replicates were set for each treatment. The virulence scoring method was described by Feng et al. (2019). (b) Virulence of MS2 and ihf mutants on potato slices. Each potato slice was inoculated with 2 μl of bacterial culture (OD600 1.0) and kept at 28°C under moist conditions. The area of lesions was measured using ImageJ v. 1.52a after 24 h. CK, negative control. ***p < 0.0001; ns, not significant (Student's t test) (n = 3 independent experiments)
FIGURE 7The regulatory network of IHF in Dickeya zeae MS2. IHF directly binds to the promoter of vfmE and affects the biosynthesis of VFM quorum‐sensing (QS) signal (A), directly interacts with the promoter of speA and indirectly interacts with speC to modulate the intracellular putrescine signal level (B), directly binds to the promoter region of the luxR‐solo homologue pipR (C), regulates the production of cell wall‐degrading enzymes (CWDEs) via multiple regulatory pathways including IHF‐VfmE, IHF‐Fis/IHF‐Fis‐VfmE (D), IHF‐ArcAB‐Fis (E), IHF‐SlyA (F), IHF‐PrtD (T1SS)/IHF‐GspC (type II secretion system) (G), directly binds to the indA promoter to regulate production of indigoidine (H), regulates the production of phytotoxin by direct binding to the hdaA promoter (I), directly binds the hrpL promoter and acts as an enhancer to activate hrpL expression, thus affecting type III secretion system effector secretion to the extracellular environment (J), and directly binds to hecB and hcp (k). IHF regulates cell motility and biofilm formation by directly binding to the flhD promoter (L), the c‐di‐GMP encoding gene gcpJ, and the pilT (M)
Strains and plasmids used in this study
| Strain or plasmid | Relevant description | Source or reference |
|---|---|---|
|
| ||
|
| ||
| MS2 | Wild type of | Laboratory stock |
| ∆ | A deletion mutant derived from MS2 | This study |
| ∆ | A deletion mutant derived from MS2 | This study |
| ∆ | A deletion mutant derived from MS2 | This study |
| ∆ | ∆ | This study |
| ∆ | ∆ | This study |
|
| ||
| CC118λ | Δ | Laboratory stock |
| DH5α |
| Laboratory stock |
| BL21(DE3) | A protein expression host for efficient exogenous genes with T7 RNA polymerase as the expression system, Kanr | Laboratory stock |
|
| ||
| pKNG101 | R6K | Laboratory stock |
| pET28b | N‐His, N‐thrombin, N‐T7, C‐His, Kanr | Laboratory stock |
| pRK2013 | Auxiliary vector, Kanr | Laboratory stock |
| pLAFR3 | Expression vector containing a p | Laboratory stock |
Tcr, Kanr, Strr indicate resistance to tetracycline, kanamycin, or streptomycin, respectively. Sucs indicates sensitivity to sucrose.